VIETER
VIETNAM MARKET INTELLIGENCE

China Anti-acne Cosmetics Market (2025 - 2030)

China Anti-acne Cosmetics Market Size & Trends

The China anti-acne cosmetics market size was estimated at USD 795.5 million in 2024 and is expected to grow at a CAGR of 11.5% from 2025 to 2030. The rising cases of acne are one of the primary factors driving the market's growth. According to the article Cureus Part of Springer Nature published in July 2025, Acne affects a considerable portion of the Chinese population, with studies indicating a prevalence rate of approximately 33% among individuals in the country. This substantial incidence emphasizes the widespread nature of the condition and highlights a consistent demand for effective skincare solutions.

The high prevalence highlights the need for advanced, accessible, and dermatologically formulated products, positioning China as a key growth region for manufacturers and brands focused on acne-related skincare.

Rising acne cases among Chinese youth drive the growth of the industry. According to the NCBI article published in September 2024, a recent study reveals that acne affects over half (50.2%) of primary and secondary school students and 44.5% of university undergraduates in China. This high incidence among adolescents and young adults underlines a significant consumer base for anti-acne cosmetic products. Additionally, regional variation in acne rates, with Southern China reporting a higher prevalence (46.3%) than Northern China (34.2%), suggests potential for region-specific marketing strategies. The awareness about skincare and appearance continues to grow, especially among younger demographics. This widespread acne occurrence is expected to drive sustained demand in China's anti-acne cosmetics industry.

Increasing preference for self-treatment fuels China's anti-acne cosmetics industry. According to the Chinese Medical Association Publishing House article published in January 2023, the study estimated that out of 483 students with acne, 366 (75.8%) reported using topical applications. In contrast, only 167 out of those 366 (45.6%) had consulted a doctor for professional treatment. This significant gap highlights a substantial consumer shift toward over-the-counter products and cosmetic solutions rather than clinical interventions. Such behavior drives the demand for anti-acne cosmetics in China, particularly among the younger population seeking accessible and quick skin issue remedies.

Several China-based manufacturers are playing a key role in driving the industry by offering advanced anti-acne cosmetic products that fall within key categories such as creams and lotions, cleansers and toners, masks, chemical peels, and specialized treatments. For example, Proya Cosmetics, headquartered in Hangzhou, has developed innovative acne care lines that integrate modern dermatological research with consumer-centric designs. Pechoin, based in Shanghai, blends traditional Chinese herbal medicine with modern skincare science, offering anti-acne creams and toners tailored for sensitive skin. Inoherb, headquartered in Shanghai, collaborates with the Shanghai University of Traditional Chinese Medicine to create herbal-based anti-acne cleansers and lotions that balance oil production and reduce inflammation.

Moreover, ZQ-II Medical Skincare has a specialized Oil Control & Anti-Acne series, including targeted gel creams and peels to treat active breakouts and prevent future acne formation. These manufacturers illustrate China’s capability to develop and deliver highly effective, scientifically informed, and consumer-friendly anti-acne cosmetic solutions, reinforcing the country’s position as a key player in the skincare industry.

Market Concentration & Characteristics

The industry is experiencing notable innovation, with manufacturers developing advanced formulations featuring natural extracts, microbiome-friendly ingredients, and dermatologically tested actives like salicylic acid and niacinamide. Companies also leverage AI-driven skin analysis apps and personalized skincare regimens to improve treatment efficacy and consumer engagement, reflecting a growing demand for tailored, science-backed acne solutions.

Key players like Zhejiang Fonow Medicine Co., Ltd., Galderma, Bloomage Biotechnology, and L'Oréal Group actively engage in mergers and acquisitions. Through these strategic moves, they focus on driving product innovation, forming essential partnerships, and expanding their geographical reach to strengthen their China anti-acne cosmetics industry position and meet the rising demand for effective and minimally invasive acne treatments in China.

Regulatory frameworks play a crucial role in the industry by enforcing product safety, efficacy, and quality standards. While stringent regulations may slow product approvals and market introduction, they help build consumer trust and ensure that only safe and effective treatments reach the market. This balance supports the market’s growth by promoting high-quality and reliable acne care solutions.

There are no direct alternatives match the effectiveness of specialized anti-acne cosmetic products. These products play a vital role in skincare routines by helping prevent and treat acne, ensuring clearer skin and improved consumer confidence.

Companies in the industry are broadening their reach by tapping into new regional markets, establishing strategic alliances with local distributors, and customizing their product portfolios to meet the unique preferences and skincare needs of different consumer groups across the country.

Treatment Insights

The creams & lotions segment held the largest share of over 37.9% in 2024. Increasing incidence of acne and strategic initiatives by the key players are driving the market's growth. Creams & Lotions in the context of anti-acne cosmetics refer to topical formulations designed to be applied directly to the skin. They are typically lightweight, easy to absorb, and formulated with active ingredients like salicylic acid, benzoyl peroxide, or natural extracts to help reduce acne, prevent breakouts, and soothe irritated skin. For instance, in January 2024, Dr. Vanbsy introduced a turmeric-infused anti-acne face cream enriched with shea butter, hyaluronic acid, vitamin C, and collagen. This night-time cream targets acne while offering anti-aging and moisturizing benefits, catering to consumers seeking natural skincare solutions.

The cleanser & toners segment is expected to grow at a significant CAGR during the forecast period. Increasing acne incidence and technologically advanced product offerings by the key players drive the market's growth. This segment includes skincare products designed to remove impurities, excess oil, and makeup (cleansers) and those used to balance skin pH, tighten pores, and refresh the skin (toners), helping manage acne and improve overall skin clarity. For instance, Guangzhou Meidishi Biotechnology Co., Ltd. offers the Beauty Cosmetics Skin Care Salicylic Acid Acne Treatment Clarifying Cleanser, formulated with 1.5% salicylic acid, green tea, and aloe vera. The cleanser aims to treat acne by reducing inflammation, controlling oil production, and cleansing pores. It's available in a 200ml size and can be customized under private labels. Moreover, Guangzhou Shiruoni Cosmetics Co., Ltd. offers Hyaluronic Acid Foam Face Wash Anti Acne Green Tea Gentle Cleanser with Brush, which combines shea butter, green tea, glycerin, and rose extracts. The product is designed for gentle cleansing and has an integrated brush for enhanced application.

Gender Insights

The female segment held the largest share of over 67.1% in 2024. Growing awareness among the population and High Reliance on Topical Acne Solutions drive the market's growth. According to the Chinese Medical Association Publishing House article published in January 2023, the study estimates that among 739 female participants (52.2% of the study population), 227 individuals (approximately 30.7%) reported using topical acne preparations, while only 47 (6.4%) had not used such treatments. This trend highlights a strong inclination among young Chinese women toward over-the-counter or cosmetic acne treatments, underscoring a significant opportunity for anti-acne cosmetic brands targeting this demographic. The widespread use suggests a higher level of awareness, access to skincare products, and a proactive approach to managing acne without immediately seeking medical consultation. This pattern also supports growth in product categories such as creams, serums, and gels formulated for female skin concerns.

The male segment is expected to grow at the fastest CAGR during the forecast period. Growing awareness and increasing demand for topical acne drive the market's growth. According to the Chinese Medical Association Publishing House article published in January 2023, the study estimates that out of the 676 male participants (47.8% of the study population), 139 individuals (20.6%) reported using topical acne treatments, while 70 (10.4%) had not used any such products. While this uptake is lower compared to the female group, the numbers still point to a growing awareness and acceptance of skincare among young men in China. This shift presents potential for market expansion into the male grooming segment, which has traditionally seen less engagement. Brands may succeed by offering gender-specific formulations or marketing strategies that normalize skincare practices among male consumers.

Distribution Channel Insights

The Over the Counter (OTC) segment held the largest share of over 62.4% in 2024. The Over-the-Counter (OTC) distribution channel in China’s anti-acne cosmetics market encompasses offline and online retail formats, enabling direct consumer access to products without needing prescriptions. Offline retail continues to play a vital role in delivering premium and experiential skincare offerings. According to the ChinaCosmetics article published in December 2024, physical stores are being reimagined as immersive spaces, featuring personalized consultations, hands-on product trials, and high-tech solutions such as AI-based skin diagnostics and augmented reality (AR) makeup try-ons. These innovations aim to elevate in-store engagement and influence buying decisions. In parallel, the online segment has surged, supported by China’s highly developed digital ecosystem. Platforms like Tmall, JD.com, Douyin, and Xiaohongshu dominate e-commerce by offering wide product assortments, competitive pricing, and seamless shopping experiences. With tools like AI-driven recommendations, livestream selling, and influencer marketing, these platforms have transformed how consumers discover and purchase anti-acne products, especially among digitally native youth.

The prescription segment is expected to grow at a significant CAGR during the forecast period. In the retail pharmacy space, chain pharmacies are increasingly offering prescription-based anti-acne products, often complemented by access to pharmacist advice. This combination makes it easier for consumers to manage skin conditions with professional support and guidance. Meanwhile, hospital pharmacies serve as critical access points for patients receiving dermatologist-prescribed treatments. These pharmacies typically stock clinically recommended or prescribed acne medications and operate under stricter regulatory supervision, ensuring the safe and effective use of medicated skincare products. Retail and hospital pharmacies play a vital role in the prescription segment by improving access to trusted and effective anti-acne solutions across urban and regional areas in China. According to the State Drug Administration article published in May 2024, China had approximately 667,000 pharmacies by the end of 2023, with chain pharmacies accounting for 57.8% of the total. This trend is especially pronounced in major cities like Shanghai, where the chain pharmacy penetration rate reached 92.2%. Leading chains such as Yifeng Pharmacy, LBX Pharmacy, and JD Health are expanding through new store openings and acquisitions, further enhancing the availability of prescription skincare products, including those used for acne treatment.

Key China Anti-acne Cosmetics Company Insights

Key players operating in the China anti-acne cosmetics market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Key China Anti-acne Cosmetics Companies:

  • Zhejiang Fonow Medicine Co., Ltd.
  • Galderma
  • Bloomage Biotechnology
  • L'Oréal Group
  • Pechoin
  • Proya Cosmetics
  • Winona
  • Johnson & Johnson
  • Unilever
  • Beiersdorf

Recent Developments

  • In May 2025,Proya Cosmetics, a key Chinese skincare brand, announced it is considering acquiring overseas brands to diversify its product offerings. The company aims to enhance its presence in various business segments, including baby care, perfume, and men's skincare, by introducing these new brands into the Chinese market.

  • In December 2024,Researchers at Central South University of Forestry and Technology developed a novel anti-acne cosmetic formulation utilizing bamboo vinegar and bamboo charcoal. This combination leverages bamboo vinegar's ability to inhibit Propionibacterium acnes and bamboo charcoal's slow-release properties to enhance the product's efficacy and minimize skin irritation. The formulation is designed to offer a sustainable and effective solution for acne treatment.

China Anti-acne Cosmetics Market